Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.NGM, Janssen sign diabetes research partnership
Both the companies will work together to evaluate selected protein factors identified by NGM in order to progress the development of potent candidates with glucoregulatory effects of bariatric
Both the companies will work together to evaluate selected protein factors identified by NGM in order to progress the development of potent candidates with glucoregulatory effects of bariatric
AggregateSpend360 is expected to relieve Ranbaxy of resources and time spent to meet the Patient Protection and Affordable Care Act’s (PPACA) state/federal aggregate spend and disclosure reporting requirements.
CAP-T CAP cells, which are immortalized cell lines, produce transient and stable protein. The CAP Technology allows for superior protein yields in a shorter time than traditional methods,
SGI-110 is a DNA-hypomethyating agent that is proven to restore silenced tumour suppressor gene expression in cancer cells by reversal of DNA methylation. Astex chief medical officer Mohammad
Designed for adult use, the Tinnitus relief spray is administered underneath the tongue two times each day to eliminate ringing in the ears, buzzing and other loud tones.
As part of the acquisition, Acuo Technologies will become part of Perceptive Software, a Lexmark company. Acuo Technologies provides performance software and services for clinical content management, data
The tablets are the generic equivalent to Endo Pharmaceuticals’ Percocet tablets to treat moderate to moderately severe pain. The tablet will be manufactured at Watson’s Miami, Florida facility
In 2007, Pfizer and Bristol-Myers Squibb had signed a global collaboration to develop and commercialize Eliquis, an investigational oral anticoagulant discovered by Bristol-Myers Squibb. Bristol-Myers Squibb chief executive
BRP is involved in the production of enzymes, lectins, protease inhibitors, organics, substrates and assay solutions for diagnostic, industrial and research use. IBEX Technologies president and CEO Paul
The acquisition will allow Quotient’s bioanalytical sciences division to form a part of LGC’s health sciences division allowing it to offer a range of products and services such